A new drug (MK-910) in the therapy of intestinal and hepatic amebiasis. First results of clinical trial.
D000328:Adult; D000368:Aged; D000563:Amebicides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004404:Dysentery, Amebic / Q000188:drug therapy*; D004748:Entamoeba histolytica / Q000187:drug effects; D005260:Female; D006801:Humans; D007866:Leg; D008101:Liver Abscess, Amebic / Q000188:drug therapy*; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced
D000563:Amebicides; D008795:Metronidazole